CD163 and chronic obstructive pulmonary disease: Kaku et al. demonstrated increased numbers of CD163+ macrophages in the alveolar space of COPD patients with GOLD stages 3 and 4 severity compared to non-smokers, smokers and COPD patients with stages 1 and 2 severity [17].